IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).

Blowout earnings and raised guidance. Ironwood Pharmaceuticals ($IRWD) is dominating the GI market with LINZESS sales up 40% YoY. We analyze why this profitable biotech is a buy despite pipeline delays.

You can't build AI on bad data. Innodata (Nasdaq: INOD) provides the essential RLHF and data engineering for Big Tech's models. With record Q3 revenue and 45%+ projected growth, this is our top AI infrastructure play.

The physical car key is dying. Strattec Security (STRT) is quietly leading the "Smart Access" revolution. With a new CEO and rising margins, this legacy manufacturer is our latest high-conviction long.